AviSia Therapeutics

Amsterdam, Netherlands · Founded 2024 · Privately Held (backing)

Developer of antigen-specific immunotherapies intended to treat autoimmune diseases. AviSia Therapeutics is based in Amsterdam, Netherlands and was founded in 2024. It has raised $410,000.

Last price · $/share
—
Implied valuation
—
Total raised
$410K
Last round
—
No prints on record

No secondary trades in AviSia Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AviSia Therapeutics with a free account
  • ·Watch AviSia Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where AviSia Therapeutics prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of AviSia Therapeutics stock.